Ascendis Pharma Inc. (ASND): Price to Sales

Corporate company logo of Ascendis Pharma Inc. (ASND)

Ascendis Pharma A/S (ASND) relies on a unique drug prolongation method, which guarantees the protection of its market positions. The current P/S multiple reflects revenue valuation dynamics, where the 14.40 indicator determines the metric's magnitude. Skytrofa provides a steady cash flow, having become the primary profit generator. However, global tensions and patent complexities could hinder the expansion of the Danish business.

Ascendis Pharma - ASND P/S Multiple (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Ascendis Pharma Inc. (ASND)

- current price and projected stock value:
Price Chart ascendispharma.com|ASND - Price Target Chart
- stock exchange capitalization data:
Market Value Ascendis Pharma Inc.|ASND - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Ascendis Pharma|ASND - Book Capitalization|Market Capitalization to Book Value ascendispharma.com|ASND - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Ascendis Pharma A/S|ASND - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Ascendis|ASND - Company Aggregate Debts|Debts to Book Capitalization Ascendis Pharma Inc.|ASND - Company Long-Term Debt|Short-Term Debt Volume Ascendis Pharma|Quick Liquidity Indicator ascendispharma.com
- financial results and valuation multiples details:
ASND - Net Profit|Expected Net Profit Ascendis Pharma A/S|ASND - Price to Earnings Ratio|Price to Future Earnings Ratio Ascendis Pharma AS|ASND - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Ascendis Pharma Inc.|ASND - Operating profit EBITDA|Net earnings per share for the last four quarters Ascendis Pharma|ASND - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months ascendispharma.com|ASND - Net earnings per share growth this year|Expected earnings per share trend next year Ascendis Pharma A/S
- issuer revenue and sales details:
ASND - Company Revenue|Company Expected Revenue ascendispharma.com|ASND - P/S Multiple|Forward Price to Sales Ascendis Pharma Inc.
General company analysis:ASND ascendispharma.com
Core merchandise of Ascendis Pharma A/S

Ascendis Pharma A/S (ASND) innovative endocrine drugs featuring extended-release technology generate high added value, directly impacting revenue growth rates. This price-to-sales ratio correlates market capitalization with annual sales volume, allowing investors to assess the premium paid for future income and determine the balance between fundamental risk and profit potential through the chart's price action.

Competitors of Ascendis Pharma A/S

Price-to-Revenue Ratio MDGL (madrigalpharma.com)|Price-to-Revenue Ratio Corcept Therapeutics Incorporated CORT|Rhythm Pharma (RYTM) - Price to Sales|AKRO - Price-to-Revenue Ratio|MTSR: Price-to-Revenue Ratio|MLTX: P/S Multiple|CRNX - Price-to-Revenue Coefficient|Price-to-Revenue Ratio NewAmsterdam Pharma Company N.V.|Soleno Therapeutics Inc (SLNO) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Amicus Pharma (FOLD)|Market Cap to Revenue 89bio Pharma ETNB|P/S Multiple AGIO (Agios Pharmaceuticals)|P/S Multiple structuretx.com GPCR|MDXG - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Rezolute Inc RZLT|LXRX: P/S Multiple|Market Cap to Revenue MBX Corp|ALT (Altimmune, Inc.) - P/S Multiple|Price to Sales aardvarktherapeutics.com AARD|Price-to-Revenue Ratio Sagimet Biosciences Inc. (SGMT)|BioAge Labs - Market Cap to Revenue Ratio|P/S Multiple BMEA (Biomea)|QNCX: Market Cap to Revenue Ratio|Fractyl Health, Inc. - P/S Multiple|Price-to-Revenue Coefficient vTv Therapeutics Inc. VTVT|agapeatpgroup.com (ATPC) - Price-to-Revenue Ratio|PLUR - Price-to-Revenue Coefficient|Market Cap to Revenue SYBX|LPCN: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Matinas BioPharma (MTNB)|SPRB: Price-to-Sales Ratio|P/S Multiple GLTO (Galecto)|Market Capitalization-to-Revenue Ratio CTCX|Lumos Pharma Corp - P/S Multiple|ONVO - P/S Multiple|Radius Recycling, Inc. (RDUS) - Price-to-Revenue Ratio